Select Medical Holdings is under investigation by law firm Bleichmar Fonti & Auld for potential breaches of fiduciary duty by its board and senior management related to its pending $16.50 per share sale. The deal, announced in March 2026, involves a consortium including company insiders who can rollover shares, unlike public shareholders. The merger requires shareholder approval in June and could close soon after, limiting scrutiny time. The investigation questions whether the board acted fairly in negotiating and disclosing the merger terms to shareholders.
AI-119 Vulcan Project Research and Engineering Company has introduced a hardware-based security system to comply with California's Executive Order N-9-26, which mandates strict safety controls on frontier AI developers like OpenAI and Google by May 2...
Micron Technology's stock is gaining strong bullish support from Wall Street, driven by its strategic focus on 3D DRAM memory technology and the growing demand for AI-related memory products. Analyst Matt Bryson from Wedbush reiterated an 'Outperform...
The Solana Policy Institute urged the SEC to judge blockchain venues for tokenized stock trading based on who controls transaction validation, censorship, and rule changes. This highlights a dispute over whether public networks with permissioned vali...
Ireland's Criminal Assets Bureau (CAB) announced it seized an additional 500 Bitcoin, increasing its total seizures in 2026 to 2,500 BTC. The bureau, which manages assets linked to crime, credited Europol’s European Cybercrime Centre for technical su...
Machi Big Brother sold three Mutant Ape Yacht Club (MAYC) NFTs for 1 Ether each on October 22 and 23, despite previously holding some for three years with higher purchase prices. Concurrently, the seller's Hyperliquid account showed a significant lev...
